Category Archives: Op-Ed

So Who’s in Charge of Medicines in Brussels?

So now we know who is to do what on health issues in the new European Commission. Or do we? The furor that the new boss of the commission, Jean-Claude Juncker, unleashed with the plans for his new team, weeks before it took office, is still reverberating around Brussels. Peter O’ Donnell reports on the […]
Also posted in Europe, Guest Blog, Regulatory | Tagged , , , , , | Leave a comment

"Sunshine" Policy Continues To Exempt CME Funding

A federal policy issued late last week appeared to deal a serious blow to continuing medical education (CME) programs supported by biopharma companies. But the specifics published by the Centers for Medicare and Medicaid Services (CMS) Oct. 31, 2014 actually continue to exempt independent CME funding from the Open Payments reporting requirements for transfers of […]
Also posted in Regulatory | Tagged , , , , , , | Leave a comment

Pulling Back the Curtains on Obamacare Rx Usage

It’s fall and the 2015 Obamacare Exchange Rx insurance offerings will be presented to patients on November 15th. But at this point, what insights do American Rx brand managers and marketers actually have on the results of the Obamacare Rx experience in 2014? Up until now, very little publicly available information on what Obamacare Rx […]
Also posted in healthcare | 1 Comment

Market Access in Ukraine

by Lana Sinichkina  and Leonid Cherniavskyi. On September 16, 2014, the Ukrainian and European parliaments ratified the EU–Ukraine Association Agreement (AA), providing for harmonization of many spheres of Ukrainian legislation with EU policy. In line with the signed AA, the government has adopted a detailed implementation plan, which endorses for preparation and approval by the […]
Also posted in Europe, Global, Guest Blog, healthcare, pricing, Regulatory | Tagged , , , | Leave a comment
  • Categories

  • Meta